Anthony is a scientist and a highly experienced Company Director and CEO.

 

He is currently an Executive Director at Servatus Biopharmaceuticals Limited and is a Non-Executive Director of The Calmer Co. Limited. He was previously CEO of The Calmer Co. (2020 – 2025) and of Australian Biotherapeutics Pty Ltd (2017-2020). Prior to this Anthony spent over 10 years at the multinational SFI Health Group (Klaire Labs, Potters Herbals, Ginsana and Flordis) where he held roles as Group Head of North Asia, Global Head of Innovation and General Manager of their SFI-Shineway Joint Venture in China.

 

Anthony holds a PhD in Cell Biology and an Executive MBA from the Australian Graduate School of Management, including a coveted exchange year at the Wharton School at the University of Pennsylvania.